About us | BERLIN-CHEMIE

Committed to health

For over 100 years, BERLIN-CHEMIE has stood for innovative research and production of newly developed as well as proven pharmaceutical products. Our goal is to introduce new drugs to help ill patients and improve their quality of life.

As part of the global MENARINI Group, the leading Italian pharmaceutical company, BERLIN-CHEMIE is responsible for the pharmaceutical markets in Germany, Eastern Europe and the CIS region.

NEWS - Latest news

Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million

5/4/2020

Helsinn Group Grants Exclusive Licensing Rights to BERLIN-CHEMIE AG, a company of the MENARINI Group, for ONICIT®/ALOXI® and AKYNZEO® in Russia and CIS region

1/27/2020

MENARINI: Elcin Barker Ergun appointed as Group CEO

9/12/2019

Helsinn Group grants exclusive licensing rights to MENARINI for Pracinostat

12/21/2018

BERLIN-CHEMIE

About us

Learn more about the business fields, the development and the history of BERLIN-CHEMIE.

MENARINI Group
READ MORE

Our Goal
READ MORE

Board of Management
READ MORE

Contact
READ MORE